Prevalence of capsular serotypes among Staphylococcus aureus isolates from cows with mastitis in the United States

Veterinary Microbiology

Volumn 59, Issue 1, 1997, Pages 53-58

  Guidry, Albert ^a,c   Fattom, Ali ^b   Patel, Atul ^b   O'Brien, Celia ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b Nabi Biopharmaceuticals   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Cattle bacteria; Mastitis; Serotyping; Staphylococcus aureus

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ISOLATION; CATTLE DISEASE; COW; MASTITIS; NONHUMAN; PREVALENCE; SEROTYPE; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ANIMALS; BACTERIAL VACCINES; CATTLE; FEMALE; FRANCE; GEOGRAPHY; MASTITIS, BOVINE; MILK; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 0031405465     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(97)00172-7     Document Type: Article

References (29)

1. Caputy, G.G., Costerton, J.W., 1984. Immunological examination of the glycocalyces of S. aureus strains Wiley and Smith. Curr. Microbiol. 11, 297-302.
2. Fattom, A., Naso, R., 1996. Staphylococcal vaccines: a realistic dream. Trends Mol. Med. 28, 43-46.
3. Fattom, A., Schneerson, R., Szu, S.C., Vann, W.F., Shiloach, J., Karakawa, W.W., Robbins, J.B., 1990. Synthesis and immunologic properties in mice of vaccines composed of S. aureus Type-5 and Type-8 capsular polysaccharides conjugated to P. aeruginosa exotoxin-A. Infect. Immun. 58, 2367-2374.
4. Fattom, A., Shiloach, J., Bryla, D., Fitzgerald, D., Pastan, I., Karakawa, W.W., Robbins, J.B., Schneerson, R., 1992. Comparative immunogenicity of conjugates composed of the S. aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or n-succinimidyl-3-(2-pyridyldithio-propionate). Infect. Immun. 60, 584-589.
5. Fattom, A., Schneerson, R., Watson, D.C., Karakawa, W.W., Fitzgerald, D., Pastan, I., Li, X.R., Shiloach, J., Bryla, D.A., Robbins, J.B., 1993. Laboratory and clinical evaluation of conjugate vaccines composed of S. aureus Type-5 and Type-8 capsular polysaccharides bound to P. aeruginosa recombinant exoprotein-A. Infect. Immun. 61, 1023-1032.
6. Foster, T.J., 1986. A new genetic approach to defining the virulence determinants of S. aureus strains that cause bovine mastitis. Ir. Vet. J. 40, 110-115.
7. Giesecke, W.H., 1979. Mastitis and milk production. Bovine Mastitis, Technical Communication No. 151, Department of Agricultural Technical Services, Republic of South Africa, Pretoria, p. 17.
8. Guidry, A.J., Oliver, S.P., Squiggins, K.E., Erbe, E.F., Dowlen, H.H., Hambleton, C.N., Berning, L.M., 1991. Effect of anti-capsular antibodies on neutrophil phagocytosis of S. aureus. J. Dairy Sci. 74, 3360-3369.
9. Guidry, A.J., Berning, L.M., Hambleton, C.N., 1993. Opsonization of S. aureus by bovine immunoglobulin isotypes. J. Dairy Sci. 76, 1285-1289.
10. Guidry, A.J., O'Brien, C.N., Oliver, S.P., Dowlen, H.H., Douglass, L.W., 1994. Effect of whole S. aureus and mode of immunization on bovine opsonizing antibodies to capsule. J. Dairy Sci. 77, 2965-2974.
11. Hill, A.W., 1981. Factors influencing the outcome of Escherichia coli mastitis in the dairy cow. Res. Vet. Sci. 31, 107-112.
12. Hoard's Dairymen. The National Dairy Farm Magazine. 1997. Annual Survey of US Milk Production, W.D. Hoard & Sons, Fort Atkinson, WI, p. 226.
13. Jasper, D.E., McDonald, J.S.D., Macro, R.D., 1982. Bovine Mastitis Research: Needs, funding and sources of support. Proc. Nat. Mastitis Council, Nat. Mastitis Council, Arlington, VA, pp. 184-193.
14. Karakawa, W.W., Vann, W.F., 1982. Capsular polysaccharides of S. aureus. In: Weinstein, L., Fields, N., Robbins, J.B. (Eds.), Seminars in Infectious Diseases, Bacterial Vaccines, Vol. IV, Thieme-Stratton, NY, pp. 285-293.
15. Karakawa, W.W., Fournier, J.M., Vann, W.F., Arbeit, R.S., Schneerson, R.S., Robbins, J.B., 1985. Method for the serological typing of the capsular polysaccharides of S. aureus. J. Clin. Microbiol. 22, 445-447.
16. Karakawa, W.W., Sutton, A., Schneerson, R., Karpas, A., Vann, W.F., 1988. Capsular antibodies induce type specific phagocytosis of capsulated S. aureus by human polymorphonuclear leukocytes. Infect. Immun. 56, 1090-1095.
17. Lee, J.C., Betley, M.J., Hopkins, C.A., Perez, N.E., Pier, G.B., 1987. Virulence studies in mice of transposon induced mutants of S. aureus differing in capsule size. J. Infect. Dis. 156, 741-750.
18. Norcross, N.L., Opdebeeck, J.P., 1983. Encapsulation of S. aureus isolated from bovine milk. Vet. Microbiol. 8, 397-404.
19. Paape, M.J., Wergin, W.P., Guidry, A.J., 1981. Phagocytic defense of the ruminant mammary gland. Adv. Exp. Med. Biol. 137, 555-578.
20. Peterson, P.K., Wilkinson, B.J., Kim, Y., Schmeling, D., Quie, P.G., 1978. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 19, 943-949.
21. Poolman, J.T., 1990. Polysaccharides and Membrane Vaccines. In: Miziahi, A. (Ed.), Advances in the Biological Process, Vol. 13, Bacterial Vaccines, Wiley-Liss, New York, pp. 57-86.
22. Poutrel, B., Boutonnier, A., Sutra, L., Fournier, J.M., 1988. Prevalence of capsular polysaccharide Types 5 and 8 among S. aureus isolates from cow, goat and ewe milk. J. Clin. Microbiol. 26, 38-40.
23. Rather, P.N., Davis, A.P., Wilkinson, B.J., 1986. Slime production by bovine milk S. aureus and identification of coagulase negative staphylococcal isolates. J. Clin. Microbiol. 23, 858-862.
24. Russell, M.W., Brooker, B.E., Reiter, B., 1976. Inhibition of the bactericidal activity of bovine polymorphonuclear leukocytes and related systems by casein. Res. Vet. Sci. 20, 30.
25. Schultze, W.D., Paape, M.J., 1984. Effect on outcome of intramammary challenge exposure with S. aureus of somatic cell concentration and presence of an intramammary device. Am. J. Vet. Res. 45, 420-423.
26. Sompolinsky, D., Samra, Z., Karakawa, W.W., Vann, W.F., Schneerson, R., Malik, Z., 1985. Encapsulation and capsular types in isolates of S. aureus from different sources and relationship to phage types. J. Clin. Microbiol. 22, 828-834.
27. Van Oss, K.J., 1986. Phagocytosis: an overview. Meth. Enzymol. 132, 3-15.
28. Welch, P.G., Fattom, A., Moore, J. Jr., Schneerson, R., Shiloach, J., Bryla, D.A., Li, X., Robbins, J.B., 1996. Safety and immunogenicity of S. aureus Type 5 capsular polysaccharide-P. aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J. Am. Soc. Nephrol. 7, 247-253.
29. Wilkinson, B.J., 1983. Staphylococcal capsules and slime. In: Easmon, C.S.F., Adlam, C. (Eds.), Staphylococci and Staphylococcal Infections, Vol. 2. Academic Press, London, pp. 481-523.